Correlation Between Apogee Therapeutics, and OmniAb

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and OmniAb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and OmniAb into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and OmniAb Inc, you can compare the effects of market volatilities on Apogee Therapeutics, and OmniAb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of OmniAb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and OmniAb.

Diversification Opportunities for Apogee Therapeutics, and OmniAb

-0.53

Correlation Coefficient

Apogee Therapeutics,  OmniAb

Excellent diversification

The 3 months correlation between Apogee and OmniAb is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and OmniAb Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OmniAb Inc and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with OmniAb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OmniAb Inc has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and OmniAb go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and OmniAb

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the OmniAb. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 3.61 times less risky than OmniAb. The stock trades about -0.04 of its potential returns per unit of risk. The OmniAb Inc is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  34.00  in OmniAb Inc on December 20, 2024 and sell it today you would earn a total of  6.00  from holding OmniAb Inc or generate 17.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	56.67%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  OmniAb Inc

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

OmniAb Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in OmniAb Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating forward indicators, OmniAb showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and OmniAb

The main advantage of trading using opposite Apogee Therapeutics, and OmniAb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, OmniAb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OmniAb will offset losses from the drop in OmniAb's long position.

The idea behind Apogee Therapeutics, Common and OmniAb Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.